Pharmacogenetics: the outlook for genetic testing in statin therapy

Nat Clin Pract Cardiovasc Med. 2005 Jan;2(1):2-3. doi: 10.1038/ncpcardio0071.
No abstract available

MeSH terms

  • Anticholesteremic Agents / therapeutic use*
  • Cholesterol, LDL / antagonists & inhibitors
  • Genetic Techniques / trends*
  • Genetic Variation / genetics
  • Genotype
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Pharmacogenetics / trends
  • Polymorphism, Genetic / genetics
  • Risk Factors

Substances

  • Anticholesteremic Agents
  • Cholesterol, LDL
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors